Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical composition comprising a crystal form of (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide for treating diffuse large B-cell lymphoma

Pharmaceutical composition comprising a crystal form of (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide for treating diffuse large B-cell lymphoma

US Patent 10640509 · Granted May 5, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Processes for the preparation of 4-{8-amino-3-[(2S)-1-(but-2-ynoyl)-pyrrolidin-22025
Salts and crystals2025
Isofagomine salts, methods of use and formulations2025
Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia 2025
Crystalline salts of 5-methyl-(6S)-tetrahydrofolic acid and amino ethyl esters2025
Crystalline salt of 5-methyl-(6S)-tetrahydrofolic acid and L-isoleucine ethyl es2025
Crystalline forms of a pharmaceutical compound2024
Crystalline monosodium salt of 5-methyl-(6S)-tetrahydrofolic acid2024
Processes for the preparation of 4-{8-amino-3-[(2S)-1-(but-2-ynoyl)-pyrrolidin-22024
Crystalline salts of 5-methyl-(6S)-tetrahydrofolic acid and L-valine ethyl ester2024
Crystalline salts of 5-methyl-(6S)-tetrahydrofolic acid and l-leucine ethyl este2024
Crystal forms of (s)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]2023